Clinical and metabolic features of neurocognitive testing in children and adolescents with type 1 diabetes mellitus
- 23 April 2024
- journal article
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 27 (8)
Abstract
Objective. To determine the presence of the link between anamnestic, clinical laboratory data and degree of cognitive impairments’ severity in children with type 1 diabetes mellitus (DM). Material and methods. The study includes the results of observations for 42 children and adolescents aged 8—16 years with a final diagnosis of type 1 DM, hospitalized as part of the annual planned hospitalization in the endocrinology department of «Children’s Hospital №1» (Tomsk) from April to July 2023. Anamnestic data, clinical laboratory manifestations of the disease, physical examination data were studied. Neuropsychological testing was conducted using the Wechsler Intelligence Scale for children and adolescents. Patients were divided into groups depending on the test results: 1st group — patients with 99 scores and less (low IQ), 2nd group — from 100 to 130 scores (average IQ), 3rd group — above 130 scores (high IQ). Results. A low IQ has been registered in 11.9% (5) of children and adolescents with type 1 DM. Analysis of anamnestic, clinical laboratory data, as well as the results of physical examination, neuropsychological testing did not show statistically significant differences between groups. Nevertheless, according to correlation analysis data, verbal IQ and overall IQ are connected by a negative correlation with the disease onset with ketoacidosis (r= –0.5 and r= –0.6 respectively), the number of past ketoacidosis episodes in history (r= –0.5), with complications presence in the form of distal sensory polyneuropathy (r= –0.5) in children and adolescents with a normal intelligence level. Non-verbal IQ and overall IQ in this group correlated with age at the disease onset (r=0.5) and the disease duration (r= –0.6). The overall IQ also had an inverse relationship with the MAU level (r= –0.5). Conclusion. Cognitive impairments in children and adolescents are registered as early as in childhood and adolescence. A potential linear relationship of age at the disease onset, the disease duration, the presence of ketoacidosis, distal sensory polyneuropathy in the history, the level of microalbuminuria with the IQ value has been identified.Keywords
This publication has 23 references indexed in Scilit:
- Cognitive function and neuroimaging characteristics in patients with childhood‐onset type 1 diabetes mellitusDiabetes/Metabolism Research and Reviews, 2023
- Prevalence and incidence of type 1 diabetes in children aged 0–14 years old in New Zealand in 2021Journal of Paediatrics and Child Health, 2023
- Update information on type 1 diabetes in children/adolescents and adultsJournal of Diabetes Investigation, 2023
- Assessment of cognitive function in young children with type 1 diabetes mellitus using electrophysiological testsPediatric Diabetes, 2022
- Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC StudyThe Lancet Diabetes & Endocrinology, 2021
- Brain Health in Children with Type 1 Diabetes: Risk and Protective FactorsCurrent Diabetes Reports, 2021
- The effect of type 1 diabetes on the developing brainThe Lancet Child & Adolescent Health, 2019
- Type 1 diabetes mellitus and school: a comparison of patients and healthy siblingsPediatric Diabetes, 2009
- Neuro-cognitive Performance in Children with Type 1 Diabetes—A Meta-analysisJournal of Pediatric Psychology, 2008
- Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitusPediatric Diabetes, 2008